Abstract: Grafted triglycerides comprising an acrylated triglyceride grafted with a fatty acid residue containing 4 to 28 carbon atoms. Also described are methods for making a grafted triglyceride and for curing a material selected from vinyl esters and unsaturated polyesters and mixtures thereof and optionally a reactive diluent. The method includes the steps of mixing a grafted triglyceride of the present invention with a material selected from vinyl esters, unsaturated polyesters and mixtures thereof to form a mixture, and curing the mixture to form a cured resin system. A cured resin system comprising a cured product obtained by the foregoing method and composites containing the cured product and a filler or reinforcing material are also disclosed. This method also includes use of the grafted triglycerides to make toughened resin and composite systems with reduced hazardous air pollutants without significantly reducing the glass transition temperature and significantly increasing the viscosity.

Abstract: A process for grain boundary engineering of an aluminum alloy of AA5XXX series which includes steps of annealing the aluminum alloy at a first temperature of from about 350° C. to about 450° C.; deforming the annealed aluminum alloy to reduce the thickness by from about 2% to about 20% of the original thickness of the aluminum alloy; heat treating the deformed aluminum alloy at a second temperature from about 450° C. to about 550° C., and optionally sensitizing the heat treated alloy in one or more sensitizing steps. Aluminum alloys of the AA5XXX series treated by the process of the present invention are also provided.

Abstract: The present invention includes compounds useful in preventing, treating or ameliorating Sigma-related disorders or diseases. The compounds of the invention can modulate cellular protein homeostasis, which includes: translation initiation, folding, processing, transport, and degradation (including ubiquitin selective autophagy) of proteins. The present invention also includes methods of preventing, treating or ameliorating a Sigma-related disorder or disease in a subject in need thereof, the method comprising administering to the subject an effective amount of a Sigma-modulating compound. The present invention also includes methods of preventing, treating or ameliorating a Sigma-related disorder or disease in a subject in need thereof, the method comprising administering to the subject an effective amount of a Sigma-modulating compound, further comprising administering an effective amount of a compound that inhibits the ubiquitin proteasome system (UPS) and/or autophagic survival pathways.

Abstract: An annealing process for treatment of an aluminum alloy of AA5XXX series which comprises steps of annealing the aluminum alloy at a first temperature of from about 350° C. to about 450° C. by a rate of temperature increase from about 0.1° C./s to about 0.5° C./s; and cooling down the annealed aluminum alloy to a temperature below 50° C. Aluminum alloys of the AA5XXX series treated by the annealing process of the present invention are also provided.

Abstract: The present invention includes a device useful for evaluating the size, shape, surface texture, mobility, rigidity, flexibility, tensile resistance or turnover rate of red blood cells in a blood sample from an individual. The device of the present invention may be used to determine if the individual suffers from a red blood cell abnormality, such as sickle cell disease.

Abstract: The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.

Abstract: The present invention pertains to an effective system and method for reducing or eliminating the formation of scale in desalination systems. The system utilizes at least one pair of electrodes in direct contact with a liquid to induce an oscillating electric field directly in a portion of the liquid or a liquid stream of the desalination system. The electric field is capable of inducing bulk precipitation of ions, minerals, salts, particulates, contaminants or a combination thereof from the liquid stream.

Abstract: The present invention is directed to compositions useful for use in separators for use in lithium ion batteries, and membranes, separators, and devices derived therefrom.

Abstract: A method for the formation of flexible surface enhanced Raman spectroscopy substrates with filtering capabilities. The method produces thin flexible substrates that have a nanoparticle ink deposited thereon. The nanoparticle ink may be any suitable nanoparticle ink which includes stabilized nanoparticles such as silver, gold or copper nanoparticles. The substrates and nanoparticle ink undergo a thermal treatment for an amount of time sufficient to remove liquid vehicle and a substantial portion of the stabilizer. The thermal treatment provides a fractal aggregate nanoparticle layer on the substrate suitable for Raman spectroscopy. Such flexible SERS substrates may be used to detect trace amounts of analyte in large volume samples.

Abstract: The present invention encompasses a class of compounds known as splice modulating oligonucleotides (SMOs) that modulate pre-mRNA splicing, thereby affecting expression and functionality of a specific protein in a cell. The present invention further provides compositions and methods for modulating pre-mRNA splicing using a SMO of the invention to abrogate disease-causing mutations in a protein. Accordingly, the present invention provides compositions and methods of treating a subject at risk of, susceptible to, or having a disease, disorder, or condition associated with aberrant or unwanted target pre-mRNA expression or activity.

Abstract: A treatment system for treating water, such as produced water that is produced during hydraulic fracturing. The system employs a combination of a plasma spark discharge and an RF oscillating electric field. The plasma spark discharge and the RF oscillating electric field may be employed simultaneously or in an overlapping manner within a chamber to treat the water. The treatment system is able to kill microorganisms as well as reduce or eliminate fouling due to, for example, bicarbonates. In some embodiments, grids are employed to further enhance the heat produced by the RF oscillating electric field.

Abstract: The invention is directed to apparatus for treating water by exposing the water to a pulsed plasma discharge. The pulsed plasma discharge is generated using a suitable electrode configuration to generate the plasma discharge in the fluid. Apparatus useful in the method may include a vessel, at least two electrodes for generating a plasma discharge in water, and a flow inlet and a flow outlet to allow water to be passed through the vessel. Also described is an in-line water treatment, where a pulsed plasma discharge is used in a pipe carrying moving water. Plasma based fluid treatment system may have many advantages in comparison to other treatment methods, such as very minimal maintenance, low operating power, and minimal pressure loss through the device.

Abstract: Systems, methods, devices, and applications for managing a binge eating disorder (BED). A smartphone and server application may be provided for monitoring and treating BED. Ecological Momentary Assessment (EMA) may be used for automated and/or manual acquisition of data related to triggers associated with BED. Risk factors may be captured in real-time to provide data to both patients and clinicians. For manual data acquisition, the user may be prompted to input emotional states, urges to binge, eating behavior, and binge episodes. For automated acquisition, time, place (e.g. via GPS), medicine adherence, and physical activity may be recorded. The user may be provided with alerts and/or interventions when it is determined that they are at risk of binging.

Abstract: A sample material is scanned with a transmission electron microscope (TEM) over multiple steps having a predetermined size at a predetermined angle. Each scan at a predetermined step and angle is compared to a template, wherein the template is generated from parameters of the material and the scanning. The data is then analyzed using local mis-orientation mapping and/or Nye's tensor analysis to provide information about local strain states.

Abstract: Disclosed is a device and method for contacting a biological substrate. A non-thermal plasma device delivers a non-thermal plasma discharge using a dielectric conduit, an igniter electrode and a RF electrode. The dielectric conduit fluidicly communicates a gas therethrough and an igniter electrode ionizes at least a portion of the gas. The RF electrode, disposed circumferentially proximate to the exterior of the dielectric conduit, generates non-thermal plasma from the ionized gas. The non-thermal plasma is discharged from the dielectric conduit and contacts a biological substrate. The non-thermal plasma discharge may be suitable for tissue bonding and sterilization applications.

Abstract: A musical keyboard touch sensor pad having a plurality of integrated sensors disposed in an array is disclosed. The plurality of integrated sensors represents a keyboard key. A processor is electronically coupled to the plurality of integrated sensors. The processor is programmed to receive signals from several of the plurality of integrated sensors and to generate a sound signal based on input from the several of the plurality of integrated sensors. The output is variable based on the number in the plurality and the location of the plurality in the array. An audio output device is electronically coupled to the processor to generate a sound based on the sound signal. A keyboard using a plurality of the sensor pads as well as a method of generating sounds from the keyboard are also disclosed.

Abstract: The invention is directed to quantification of the effects of drugs on a patient using pupillometric measures. Apparatus and processes for obtaining control and patient measures and deriving relationships from same are provided. The methods of the invention provide doctor quantitative feedback on patient symptoms and on the effects of a drug or dosage of same on a patient, as well as provide assessment capability to patients and law enforcement.

Abstract: A bi-directional antenna includes a plurality of unit cells stacked in two perpendicular planes (Y-X and Z-X planes) to form cube shaped unit cells whereby inductive loops are placed on four faces corresponding to the Y-X and Z-X planes. Each unit cell includes a magnetic permeability enhanced metamaterial. The resulting antenna has the ability to couple magnetic fields oriented in both the X and Y directions with increased permeabilities and can be used to realize a variety of different antenna architectures that do not have their magnetic field confined in a single direction.

Abstract: Full-AC load flow constitutes a core computation in power system analysis. A performance gain with a hardware implementation of a sparse-linear solver using a Field Programmable Gate Array (FPGA) is achieved by use of a DC network emulation of the power system bus. Analog Behavioral Models (ABMs)are used in an efficient strategy for designing analog emulation engines for large-scale power system computation. A generator model is also developed using analog circuits for load flow emulation for power system analysis to reduce computation time. The generator model includes reconfigurable parameters using operational transconductance amplifiers (OTAs). The circuit module is used with other reconfigurable circuits, i.e., transmission lines and loads.

Abstract: The present invention provides a method of inhibiting, suppressing or preventing levodopa-induced dyskinesia in a patient suffering from Parkinson's Disease, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention. The present invention further provides a method of inhibiting, suppressing or preventing Parkinson's Disease in a patient, comprising the step of administering to the patient a pharmaceutical composition comprising at least one compound of the invention.